Supercritical fluid extraction-liquid chromatography method development for a polymeric controlled-release drug formulation.
We have recently been involved in the development of a method for assaying the active component in a controlled-release drug formulation, which is composed of a drug substance covalently bonded to polymer matrix. The drug substance in the formulation is the active enantiomer of misoprostol, a synthetic analog of natural prostaglandins and the active ingredient in Cytotec. Our method development consisted of a systematic evaluation of dynamic, off-line supercritical fluid extraction (SFE) as sample preparation for the formulation assay. Extracts were analyzed with normal phase and reversed-phase HPLC methods. The reversed-phase system utilized postcolumn reaction to provide selective detection of the extracted prostaglandin sample components. Several SFE parameters were investigated to optimize the recovery of the drug substance from the formulation, including sample quantity, extraction cell volume, extraction duration, supercritical carbon dioxide modifier, temperature, pressure, and collection solvent. The SFE experiments were completed with a commercially available multicell extractor. Preliminary validation studies utilized a formulation made with radiolabeled drug to determine the recovery achieved under the optimized SFE conditions and assessed the precision of replicate determinations. Analysis was completed under the optimized conditions to quantitate levels of the active component and related compounds in lots of the experimental polymeric formulation and to determine the total weight per cent extracted.
Roston
D A
DA
Searle Research and Development, Skokie, Illinois 60077, USA.
Sun
J J
JJ
Collins
P W
PW
Perkins
W E
WE
Tremont
S J
SJ
D002245:Carbon Dioxide / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D002853:Chromatography, Liquid; D003692:Delayed-Action Preparations / Q000032:analysis*; D007202:Indicators and Reagents; D007553:Isotope Labeling; D016595:Misoprostol / Q000032:analysis; D011108:Polymers; D012997:Solvents; D013056:Spectrophotometry, Ultraviolet
D003692:Delayed-Action Preparations; D007202:Indicators and Reagents; D011108:Polymers; D012997:Solvents; D016595:Misoprostol; D002245:Carbon Dioxide